العربية

Archive for 2009

The Nebraska Medical Team Visits KFSHD

The Nebraska Medical team’s first visit to KFSH-D lasted for three days. During their visit they surveyed several hospital departments, met with the departments’ administrators and consultants, and attended presentations about the specialized services each department provides.

The Nebraska Medical Center, is known for its specialization in Bone Marrow and Organ Transplant, it is also known for their Advanced Epilepsy Center. Nebraska Medical Center has shared its experience with a number of international centers including China, India and King Faisal Hospital in Jeddah. And now, KFSH-D will be added to the list.

Dr. Nizar Mamdani, the Executive Director of International Health Services said that he was very impressed with the leadership and enthusiasm of the consultants and staff of the hospital; he has high hopes for future collaborative efforts set to happen, as he states “Our Goals are alike”.

Physicians Who Practice At The Nebraska Medical Center On Best Doctors List

A total of 192 physicians who practice at The Nebraska Medical Center have been recognized on this year’s list of Best Doctors in America®. The doctors include 156 full and part-time faculty at the University of Nebraska Medical Center and who are also affiliated with UNMC Physicians, the UNMC practice group.

 

The list of physicians was excerpted from the Best Doctors in America® 2009-2010 database of over 45,000 doctors in more than 40 specialties, which represents the top 3 to 5 percent of specialists in the country.

 

Physicians are selected on the basis of the question: “If you or a loved one needed a doctor in your specialty, to whom would you refer them?” A peer-review survey by thousands of doctors determines the doctors included in the database. Only those doctors who earn the consensus support of their peers are included and only physicians in the Best Doctors database are allowed to receive the survey, nominate others and vote.

 

Best Doctors in America® was founded in 1989 by two physicians affiliated with Harvard Medical School and is today a leading resource to those seeking medical advice and information.

 

The Nebraska Medical Center physicians featured in the 2009-2010 database are identified below.

 

UNMC Physicians

 

Joseph C. Anderson, Radiology
Dean L. Antonson, Pediatric Specialist
Kimberly Ann Apker, Radiology
James O. Armitage, Medical Oncology and Hematology
Hari Bandla, Pediatric Specialist
Teri Jo Barkoukis, Sleep Medicine
Teresa Grace Berg, Obstetrics and Gynecology
John M. Bertoni, Neurology
Joel Bessmer, Internal Medicine
Philip J. Bierman, Medical Oncology and Hematology
Jean Frederick Botha, Surgery
Susan Boust, Psychiatry
Julia A. Bridge, Medical Genetics & Pathology
Bruce A. Buehler, Medical Genetics
William J. Burke, Psychiatry
Wing C. (John) Chan, Pathology
Peter F. Coccia, Pediatric Specialist
Samuel M. (Sam) Cohen, Pathology
John L. Colombo, Pediatric Specialist  
Kevin P. Corley, Pediatric Specialist
Kenneth H. Cowan, Medical Oncology and Hematology
David A. Danford, Pediatric Specialist
Cyrus Victor DeSouza, Endocrinology and Metabolism
Kim F. Duncan, Pediatric Specialist
Arthur R. Easley, Cardiovascular Disease
Catherine M. Eberle, Geriatric Medicine
James Edney, Surgical Oncology
Charles A. Enke, Radiation Oncology
Christopher C. Erickson, Pediatric Specialist
Paul Esposito, Pediatric Specialist
Pierre B. Fayad, Neurology
Edward Vincent Fehringer, Orthopaedic Surgery
David Finken, Pediatrics
Mark H. Fleisher, Psychiatry
Kenneth A. Follett, Neurological Surgery & Pain Medicine
Alison Gail Freifeld, Infectious Disease
Kevin L. Garvin, Orthopaedic Surgery
James Gigantelli, Ophthalmology
Glen M. Ginsburg, Pediatric Specialist
Dennis P. Goeschel, Family Medicine
John L. Gollan, Gastroenterology & Hepatology
Whitney Sears Goldner, Endocrinology and Metabolism
Bruce Gordon, Pediatric Specialist
Carl Greiner, Psychiatry
Timothy Greiner, Pathology
Carl H. Gumbiner, Pediatric Specialist
Jud W. Gurney, Radiology
Daniel E. Halm, Family Medicine
James Martin Hammel, Thoracic Surgery
Christine P. Hans, Pathology
Jeffrey Harrison, Family Medicine
Brian Hasley, Pediatric Specialist
Kristie Denise Hayes, Dermatology
Leslie Hellbusch, Pediatric Specialist/Neurological Surgery
Steven H. Hinrichs, Pathology
Ronald R. Hollins, Plastic Surgery 
Barbara J. Hurlbert, Anesthesiology
Thomas J. Imray, Radiology
Kimberly Jean Jarzynka, Family Medicine
Sonny L. Johansson, Pathology
Perry Johnson, Plastic Surgery
Andre Kalil, Infectious Disease
Margaret Anne Kessinger, Medical Oncology and Hematology
Lynell W. Klassen, Rheumatology
Christopher J. Kratochvil, Pediatric Specialist/Child and Adolescent Psychiatry
John Dale Kugler, Pediatric Specialist
Rudy Paul Lackner, Thoracic Surgery
Amy E. Lacroix, Pediatrics
James T. Lane, Endocrinology and Metabolism
Alan N. Langnas, Surgery
Jennifer L. Larsen, Endocrinology and Metabolism
Paul D. Larsen, Pediatric Specialist/Neurology
Audrey Lazenby, Pathology
Subodh M. Lele, Pathology
Peter J. Lennarson, Neurological Surgery
Donald A. Leopold, Otolaryngology
Gary Stephen Lerner, Pediatrics
Richard E. Lutz, Pediatric Specialist
Daniel D. Lydiatt, Otolaryngology
William M. Lydiatt, Otolaryngology
Thomas G. Lynch, Vascular Surgery
William L. Lyons, Geriatric Medicine
Lynn Mack-Shipman, Endocrinology and Metabolism
Thomas M. Magnuson, Psychiatry 
Mark E. Mailliard, Gastroenterology & Hepatology
Timothy Raymond, Malloy Geriatric Medicine
Rodney S. Markin, Pathology
Monty S. Mathews, Family Medicine
Timothy M. McCashland, Hepatology
Rodney D. McComb, Pathology
Ted Mikuls, Rheumatology
Timothy E. Moore, Radiology
Matthew A. Mormino, Orthopaedic Surgery
Debra E. Mostek, Family Medicine
Robert Muelleman, Emergency Medicine
Sandeep Mukherjee, Hepatology
Peter James Murphy, Pulmonary Medicine
Amy S. Neumeister, Endocrinology and Metabolism
J. Scott Neumeister, Internal Medicine
Nils Nystrom, Hand Surgery
David V. O’Dell, Internal Medicine
James R. O’Dell, Rheumatology
Jennifer Parker, Internal Medicine & Pediatrics
Audrey Paulman, Family Medicine
Paul M. Paulman, Family Medicine
Craig Arnold Piquette, Critical Care Medicine & Pulmonary Medicine
Samuel Pirruccello, Pathology
Sheryl L. Pitner, Pediatrics
Jill Adair Poole, Allergy and Immunology
Thomas R. Porter, Cardiovascular Disease
Jane F. Potter, Geriatric Medicine
Laurel C. Preheim, Infectious Disease
Mohammed Abdul Quader, Thoracic Surgery
Elizabeth C. Reed, Medical Oncology and Hematology
Stephen I. Rennard, Pulmonary Medicine
William Bradley Rizzo, Pediatric Specialist
William H. Roccaforte, Psychiatry
Kerry J. Rodabaugh, Obstetrics and Gynecology
Debra J. Romberger, Pulmonary Medicine & Critical Care Medicine
Mark E. Rupp, Infectious Disease
Paul H. Sammut, Pediatric Specialist
Aaron R. Sasson, Surgical Oncology & Surgery
Daniel F. Schafer, Gastroenterology & Hepatology
Susan A. Scherl, Pediatric Specialist
Tina Scott-Mordhorst, Pediatrics
Patricia Seivert, Pediatrics
Byers W. Shaw, Jr., Surgery
Vijay Shivaswamy, Endocrinology and Metabolism
Edibaldo Silva-Lopez, Surgical Oncology
Joseph H. Sisson, Critical Care Medicine & Pulmonary Medicine
Michael A. Sitorius, Family Medicine
Carl V. Smith, Obstetrics and Gynecology
John Lloyd Smith, Family Medicine
Philip W. Smith, Infectious Disease
Russell B. Smith, Otolaryngology & Surgery
Michael F. Sorrell, Hepatology
John Wesley Sparks, Pediatric Specialist/Neonatal-Perinatal Medicine
Sharon Stoolman, Pediatrics
Todd W. Stull, Psychiatry
Thomas Gerald Tape, Internal Medicine
John H. Tinker, Anesthesiology
Edward Vandenberg, Family Medicine & Geriatric Medicine
Jon A. Vanderhoof, Pediatric Specialist
Susanna Gertrude Von Essen, Critical Care Medicine & Pulmonary Medicine
Julie M. Vose, Medical Oncology and Hematology
John N. Walburn, Pediatrics
Craig W. Walker, Radiology
Phyllis I. Warkentin, Pathology
Dennis D. Weisenburger, Pathology
Steven Wengel, Psychiatry
Douglas H. Wheatley, Family Medicine
Robert Swift Wigton, Internal Medicine
John Windle, Cardiovascular Disease
James L. Wisecarver, Pathology
Renee L. Young, Gastroenterology
Weining (Ken) Zhen, Radiation Oncology

Private Practice Physicians

 
Garnet J. Blatchford, Colon and Rectal Surgery
David E. Brown, Orthopaedic Surgery
Charles Burt, Orthopaedic Surgery
Derek Burdeny, Radiology
James Canedy, Orthopaedic Surgery
John Joseph Cannella, Internal Medicine
Robert M. Cochran, Hand Surgery
James Richard Commers, Medical Oncology and Hematology
Harris A. Frankel, Neurology 
Mark E. Goebel, Orthopaedic Surgery
George Greene, Neurological Surgery
Michael A. Halsted, Ophthalmology
T. J. Holmes, Internal Medicine
Brett Kettelhut, Allergy and Immunology
Timothy K. Kingston, Surgery
Sarah B. Konigsberg, Endocrinology and Metabolism
Lonny Joe Legino, Obstetrics and Gynecology
Rodney P. Lusk, Pediatric Specialist/Otolaryngology
Paul H. Meissner, Family Medicine
Gordon S. Moshman, Family Medicine
Randall D. Neumann, Orthopaedic Surgery
Mark D. Omar, Internal Medicine
Richard K. Osterholm, Internal Medicine
William R. Palmer, Rheumatology
Douglas Ramos, Plastic Surgery
Edwin Conrad Schafer II, Gastroenterology
Joseph F. Shehan, Internal Medicine
Kent H. Siemers, Obstetrics and Gynecology
Ann Meissner Sjulin, Obstetrics and Gynecology
Karen J. Stacey, Internal Medicine
Britt A. Thedinger, Otolaryngology
Alan G. Thorson, Colon and Rectal Surgery & Surgical Oncology
Timothy O. Wahl, Endocrinology and Metabolism
Peter J. Whitted, Ophthalmology
Thomas Whittle, Vascular Surgery

August 2009-Dr. Fu receives award to support his lymphoma research

Story contributed by the Lymphoma Research Foundation

 
 New ways to attack an aggressive and incurable type of lymphoma will be studied at UNMC with the help of a $300,000 grant from the Lymphoma Research Foundation (LRF).
Kai Fu, M.D., Ph.D., associate professor of pathology and microbiology, has received the grant — called the 2009 Millennium Pharmaceuticals, Inc./Lymphoma Research Foundation Clinical Investigator Career Development Award — to support his mantle cell lymphoma research.   This substantial investment by the Lymphoma Research Foundation is indicative of the group’s high esteem for Dr. Fu’s work, said Tom Rosenquist, Ph.D., vice chancellor for research at UNMC.  
 

More about the award

The three-year Clinical Investigator Career Development Award is designed to fund training of clinicians who will participate in developing new therapeutics and diagnostic tools for lymphoma.

The focus of the training is to prepare clinicians to design and administer clinical studies in lymphoma and to take on the primary responsibilities for clinical trial design, protocol writing, Institutional Review Board (IRB) submission, and publication.

Dr. Fu will pursue a career development plan with the guidance of his mentor, Wing (John) Chan, M.D., Amelia and Austin Vickery Professor of Pathology and co-director of the UNMC Center for Lymphoma and Leukemia Research.

“Dr. Fu has been highly productive in lymphoma research and I am glad that his potential as a physician-scientist is recognized by the LRF with a career development award,” Dr. Chan said. “We are grateful for this award that will provide essential supports during his transition to be an independent investigator.”

“I know that, with his innovative research approach and high level of energy, the investment will pay dividends in new, improved therapy for patients with mantle cell lymphoma,” he said.  

Lymphoma — the most common type of blood cancer — is broadly categorized into Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL). According to the World Health Organization, there are six types of HL and more than 61 types of NHL.  

Mantle cell lymphoma is a rare B-cell NHL that is very aggressive. It accounts for 6 percent of all new diagnoses of NHL — or about 3,000 new cases per year in the United States. 

The disease:

  • Typically affects men older than 60;
  • Frequently is diagnosed in Stage IV;
  • Often is present in lymph nodes above and below the diaphragm; and
  • In most cases involves the gastrointestinal tract and bone marrow.

It is characterized by over expression of the gene called cyclin D1 due to a chromosomal translocation. 

A subset of mantle cell lymphoma also shows higher levels of a group of small RNA molecules, called miR-17~92. 

Dr. Fu and his colleagues have found that this higher expression correlates directly with poorer patient survival. These findings indicate that higher miR-17~92 expression induces abnormal activation of a pathway in tumor cells that leads to increased resistance to standard chemotherapy.  

About the foundation

The Lymphoma Research Foundation (LRF) is the nation’s largest voluntary health organization devoted exclusively to funding lymphoma research and providing patients and health care professionals with critical information on the disease. LRF’s mission is to eradicate lymphoma and serve those touched by this disease.

As of June 30, 2008, LRF had funded more than $37 million in lymphoma-specific research. The foundation is the world’s largest private funder of mantle cell lymphoma research.

 

This recent award will help Dr. Fu conduct a pre-clinical study to determine whether suppression of miR-17~92 will improve the effect of chemotherapy. His study may lead to a novel approach to treat MCL patients.

“Dr. Fu’s elegant proposal explores a new avenue for understanding MCL and identifying potential therapeutic targets,” said Michael Williams, M.D., director of the University of Virginia’s Hematologic Malignancy Program and chairman of the LRF’s Mantle Cell Consortium, of which Dr. Fu also is a member. “We are delighted that Dr. Fu has chosen MCL as the focus of his Clinical Career Development Project.”

 
 

Date Published: Wednesday, August 12, 2009

Dr. Ikezu discovery nets large venture capital investment

by Lisa Spellman, UNMC public relations
 
A recently discovered enzyme with big implications in the treatment of neurodegenerative disorders has led to the largest acquisition of venture capital funds obtained to date by UNeMed Corporation and UNMC. 

NuMedix Health Group, a venture capital firm in Sydney, Australia, has invested about $2 million in the research of Tsuneya Ikezu, M.D., Ph.D., a professor in the department of pharmacology and experimental neuroscience at UNMC.

 

The money will help further Dr. Ikezu’s work to find a compound to block the newly-discovered enzyme’s function and subsequently prevent the damaging effects of the enzyme’s overactivity — which contributes to the onset of dementia.

 

“The University of Nebraska Medical Center has an international reputation in producing quality research and Dr. Ikezu has done an impressive amount of research in this particular area,” said Michael Issakidis, NuMedix managing director. “We hope that by our investments, we can assist hundreds of thousands of individuals and their families in achieving a better quality of life.”

 

UNeMed first filed a patent application on this enzyme when Dr. Ikezu discovered it in 2002 and just received word that the U.S. Patent and Trademark Office expects the patent to issue later this summer.

 

“The reward of UNeMed and Dr. Ikezu’s diligence over the past six years is paying large dividends,” said Michael Dixon, Ph.D., president of UNeMed. “Everything has come together nicely and we are pleased to be able to attract additional research money to this valuable research as well as establish a partner to help translate the results of this research into the clinic.”

 

Enzyme does damage in mouse models

 

Dr. Ikezu’s lab developed a transgenic mouse model to show that the enzyme — known as tau-tubulin kinase1 (TTBK1) — induces memory impairment.

 

The study in the mouse model was published in the December Journal of Neuroscience and revealed that TTBK1 is a potential therapeutic target for neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases.

 

“We are all excited about the publication and funding for initiating the drug screening program to regulate this enzyme activity in brain,” Dr. Ikezu said.

 

Company takes notice of Dr. Ikezu’s work

 

Nearly a year ago, UNeMed was approached by Neumedix in regards to Dr. Ikezu’s work. Due to the complex nature of the project, negotiations and plans took nearly several months to complete and work began April 1.

 

The research will take place over the next four years at which time, it is anticipated that it will be ready for clinical trials.

 

Dr. Ikezu is optimistic a compound can be identified through the drug discovery endeavor.

 

“I really appreciate all the lab members contributing to this project, support from department of pharmacology and experimental neuroscience, and UNeMed for identifying the sponsorship,” Dr. Ikezu said. 

 

 
 
Date Published: Friday, May 29, 2009

Dr. Campbell receives international award for health records efforts

by Tom O’Connor, UNMC public relations

A leader in the development of a compatible worldwide system for electronic health records, UNMC’s James Campbell, M.D., has earned a prestigious international award for his pioneering work. 

Dr. Campbell, who has devoted nearly 30 years to development of an electronic health record system, received the first-ever Award for Excellence from the International Health Terminology Standards Development Organisation (IHTSDO), a non-profit association in Denmark.

 

IHTSDO evolved from a project that originated in the United States known as SNOMED CT (Systematized Nomenclature of Medicine–Clinical Terms). For years, Dr. Campbell was a proponent for the use of SNOMED CT in clinical settings primarily in the United States but also around the world.

 

More about Dr. Campbell

Hometown: Geneva, N.Y.

Education: Bachelor’s degree in physics, University of Rochester, (N.Y.); medical degree, UNMC, 1976

Training: Internal medicine residency and fellowship, UNMC

Faculty positions: Internal medicine instructor, 1980-1981; assistant professor, 1981-1990; associate professor, 1990-2000; professor, 2000-present.

Other positions: Medical director for clinical information systems development for UNMC’s hospital partner, The Nebraska Medical Center, 1998-present.
 

 

“There have been many barriers to making electronic health records a reality,” Dr. Campbell said. “With the free enterprise system, there are lots of different vendors who have the expertise. We needed to develop an infrastructure, and that’s where SNOMED CT comes in. It allowed us to standardize the various components of the medical record.”

 

 President Barack Obama has made electronic health records a priority in his administration, Dr. Campbell said.

 

“This is a critical element under President Obama’s economic stimulus package,” he said. “He has created incentives to encourage health care providers to get this done in the next two to three years. This has created a sense of urgency among providers.”

 

Dr. Campbell received the award at a gala conference dinner in Helsingor, Denmark, on March 31-April 1.

 

SNOMED CT has become an international operation, including foreign countries such as the United Kingdom, Canada, New Zealand, Singapore, Lithuania and Sweden.

 

 The Award of Excellence is given for outstanding contributions to the improvement of SNOMED CT and/or its successful implementation in any aspect of health and social care. IHTSDO officials said Dr. Campbell was recognized for volunteering hundreds of hours of his time to participate in weekly conference calls, provide support for document development, and schedule global face-to-face meetings.

 

“Since his innovative introduction of the electronic medical record at UNMC in the early 1980s, Jim has positioned UNMC to be a true leader in this area at both the national and international level.”

Lynell Klassen, M.D

 

In addition to his international work in standardizing electronic health records, Dr. Campbell also has been active in the electronic health information initiative in Nebraska. His work has earned the attention of his UNMC peers.

“Dr. Campbell has been a pioneer in the development and use of the electronic medical record,” said Lynell Klassen, M.D., professor and chairman of the UNMC Department of Internal Medicine. “Since his innovative introduction of the electronic medical record at UNMC in the early 1980s, Jim has positioned UNMC to be a true leader in this area at both the national and international level. His activities benefit our patients, our providers and the entire state on a daily basis.”

 

Date Published: Wednesday, May 27, 2009

May 2009-Dr. Fayad named AHA Physician of the Year

Story contributed by The American Heart Association

Pierre Fayad, M.D., Reynolds Centennial Professor and chairman in the UNMC Department of Neurological Sciences, has been named the American Heart Association Physician of the Year.

 

Dr. Fayad — who also is director of the stroke center at UNMC’s hospital partner, The Nebraska Medical Center — received the award during a ceremony in Washington on Monday.

 

The award is conferred annually upon the practicing physician who has rendered “outstanding contributions” toward accomplishing the American Heart Association mission. Dr. Fayad was honored for being a pioneer and leader in numerous initiatives to improve the health of his community, especially in the area of stroke.

 

“This is a wonderful honor for one of our truly outstanding physicians,” said John Gollan, M.D., Ph.D., dean of the College of Medicine. “Dr. Fayad’s work in the field of stroke certainly merits this national recognition.

 

“This is excellent news for Dr. Fayad, the College of Medicine and UNMC as a whole.”

 

As stroke center director, Dr. Fayad established and now leads a stand-alone outpatient neurological clinic that received more than 7,000 patient visits in 2008. He also oversees a multidisciplinary “Stroke Code Team” that is responsible for the care of patients with acute stroke.

 

Countless patients have benefited from Dr. Fayad’s neurological expertise, including Lenice Hogan of Omaha.

 

“I have a complicated medical history and every time I was in the hospital I was told something different and would leave with no idea what the problem was or where to turn,” she said. “From the moment I met Dr. Fayad, I felt absolutely at ease. He took my records and spent a month researching other patients in the world with my condition — he found three. I’m not scared of what lies ahead because I know he’s on top of everything.”

 

Brenda Barry of Woodbine, Iowa, credited Dr. Fayad with saving her husband Lynn’s life.

 

“My husband had been having a series of mini strokes for a few weeks,” Barry said. “They would hit him for a few minutes and then he would go about his day like nothing had happened. We knew it wasn’t normal, but it was easy to let it go.”

 

Until they met with Dr. Fayad.

 

“In our initial appointment with Dr. Fayad, he was very thorough and quickly diagnosed the seriousness of the situation,” Barry said. “As far as we’re concerned, he saved my husband from having a massive stroke that could have paralyzed or killed him. Lynn is healthier than he has been in a decade or longer.”

 

Under Dr. Fayad’s leadership, the medical center’s stroke center became the first in Nebraska to be certified as a Primary Stroke Center by the Joint Commission.

 

In 2008, The Nebraska Medical Center was recognized with the Gold Achievement Award of the American Heart Association’s Get With The Guidelines-Stroke program, which recognizes 24 consecutive months of providing care that meets or exceeds stroke treatment guidelines set by the association.

 

Stewart Becker of Omaha suffered a stroke while on a skiing vacation in Colorado. After a week in a Denver hospital, he came home to Omaha and met with Dr. Fayad.

 

“The perception was that in the middle of the country I wouldn’t have the resources I needed (as a stroke survivor),” Becker said. “In Dr. Fayad, I’ve got an individual with a great reputation with a great institution, and I can get as good of care right in my home city as I could get anywhere.”

 

Dr. Fayad currently chairs the Advisory Committee of the American Stroke Association, a division of the American Heart Association. He is also a member of the association’s International Stroke Conference Program Committee and National Science Advisory & Coordinating Committee.

April 2009-16 UNMC physicians named America's Top Doctors

Consumers searching for a quality physician in the eighth edition of Castle Connolly’s “America’s Top Doctors” book will find the names of 16 UNMC faculty members.
Several of those awarded the high honor have been chosen “top doctors” in the past. Most of the UNMC physicians see patients at UNMC’s hospital partner, The Nebraska Medical Center.

 

The full-time faculty and their specialties are:

 

James Armitage, M.D. — oncology
Phillip Bierman, M.D. — oncology
William Burke, M.D. — geriatric psychiatry
Kenneth Cowan, M.D. — oncology
Jim Edney, M.D. — surgery
Kevin Garvin, M.D. — orthopedic surgery
James Gigantelli, M.D. — ophthalmology
Carl Greiner, M.D. — psychiatry
Thomas Howard, M.D. — vascular surgery
Donald Leopold, M.D. — otolaryngology
William Lydiatt, M.D. — otolaryngology
Steven Remmenga, M.D. — gynecologic oncology
Michael Sorrell, M.D. — gastroenterology
Paul Tomich, M.D. – maternal fetal medicine
Julie Vose, M.D. — hematology
Dennis Weisenburger, M.D. — pathology

 

Criteria for making the list include education, board certification, reputation, experience and disciplinary history, as well as interpersonal skills such as empathy, being a good communicator, educator and someone who can instill trust and confidence.

 

“We’re delighted to have our physicians continue to rank among the best in quality health care,” said John Gollan, M.D., Ph.D., dean of the UNMC College of Medicine. “They help make UNMC a place where people entrust us with their health and the health of their families.”

 

Physicians are nominated by their peers in a Castle Connolly survey process each year. Physicians then are screened by a Castle Connolly physician-led research team who rank among the best in their specialties and in their communities.

 

In addition to nominations from practicing physicians, Castle Connolly solicits nominations from hospital presidents, vice presidents of medical affairs and nursing, chiefs of service in anesthesiology, OB/GYN, medicine, emergency medicine, pediatrics, psychiatry, radiology and surgery. 

 
Date Published: Monday, March 9, 2009

Breakthrough Technology for Heart Failure Patients Now Available at The Nebraska Medical Center

Omaha, Neb – Dewey Smith thought he was sick. When the 61-year-old Council Bluffs, IA man drove himself home from work one morning in February, he didn’t realize he was quickly dying.

 

“I don’t remember calling 911,” said Smith. “By the time I got to the hospital, my heart had stopped – I had no pulse.”

 

Staff at another local hospital revived Smith, and told him he had a massive heart attack.

 

“We were on the phone making my funeral arrangements,” remembered Smith. One of his doctors made a different call – to The Nebraska Medical Center.

 

“The FDA had just approved the use of the HeartMate II,” said Ioana Dumitru, MD, heart failure specialist at The Nebraska Medical Center. “Dewey seemed to be an excellent candidate for its use. He would have died without it.”
Smith was transferred to The Nebraska Medical Center for surgery to implant the HeartMate II.

 

“It’s an open heart surgery,” explained Mohammad Quader, MD, cardiothoracic surgeon and director of the heart transplant program at The Nebraska Medical Center. “We connect the device to the left ventricle of the heart. The blood travels from the left ventricle into the pump, and then the pump pushes blood into the aorta.” The HeartMate II provides several advantages over previous mechanical assist devices.

 

“It’s more reliable,” said John Um, MD, cardiothoracic surgeon at The Nebraska Medical Center. “It has fewer moving parts than other devices, so it’s less likely to have problems. Fewer parts mean smaller size. That allows us to implant the device in smaller patients; women, even teenagers. These are people who would not have been able to have a mechanical assist device before.”

 

Other mechanical assist devices use pressurized air to propel the blood around the body. The HeartMate II uses a small turbine, similar to a screw, which spins and moves the blood. The device also requires a constant energy supply. Patients must keep the device plugged into an electrical outlet or a mobile battery pack.

 

March 2009-Medical center to host internationally recognized nurse scientist

by Vicky Cerino, UNMC public relations 
 

The UNMC Eppley Cancer Center, the College of Nursing and The Nebraska Medical Center will host Carol Estwing Ferrans, Ph.D., next month.

 

Dr. Ferrans will be the UNMC Eppley Cancer Center grand rounds speaker and the college’s 20th Visiting Nurse Scholar.

 

Dr. Ferrans, associate dean for research and professor at the University of Illinois at Chicago College of Nursing, will present “Research: Exposing the Deadly Difference” during an April 14 Eppley Cancer Center grand rounds luncheon presentation on campus.

 

The UNMC College of Nursing and The Nebraska Medical Center also will co-host a community presentation and reception that evening.

 

Dr. Ferrans also will make other presentations at the college and The Nebraska Medical Center, as well as meet with individuals.

 

The professor, who also is deputy director of the University of Illinois Center for Population Health and Health Disparities, has conducted studies focused on quality of life and disparities in health care for 20 years. She is funded by the National Institutes of Health.

 

An important part of her research has focused on cross-cultural issues, including approaches to increase validity of data and participation in research for minority populations in the United States.

 

Ann Berger, Ph.D., who will direct Dr. Ferrans’ visit to the UNMC College of Nursing, said Dr. Ferrans’ talk will focus on a program in Chicago to increase early detection of breast cancer among women of diverse backgrounds and economic levels.

 

The luncheon will be held at noon in the Durham Research Center Auditorium. Lunch will be served on a first-come, first-served basis. No reservation required.

 

Reservations for the dinner presentation are required. RSVP by April 2 to concne@unmc.edu or call 559-6565. Those who make reservations are asked to provide name, nursing license number, state of licensure, address, phone number and e-mail.

 

Free continuing education credits are available during both talks.

 
Date Published: Monday, March 23, 2009

February 2009-Surgical airway innovations showcased at national conference

by Shelby Buettner of the Center for Advanced Surgical Technology

The conference was held in Long Beach, Calif., in late January.

 

“This is an established and widely attended international conference that has presented an opportunity for us to exhibit our cutting-edge research,” said Dmitry Oleynikov, M.D., UNMC associate professor of surgery and director of minimally invasive surgery who also directs CAST. “University of Nebraska researchers had a very large presence, which has placed Nebraska on the global radar in surgical innovation.”

 

Faculty, staff and student researchers made presentations about expanding university research and collaborative multi-disciplinary research projects, including miniature robots for surgery, novel airway management solutions, telemedicine capabilities for perioperative medicine care, proficiency in robotic surgery and surgical applications of robotic and mechanical systems.

 

“The conference … provides a venue to network and foster collaboration with other like-minded researchers,” said Ben Boedeker, M.D., Ph.D., UNMC professor of anesthesiology who also works in the Center for Advanced Airway Technology.

 

Aside from Drs. Oleynikov and Boedeker, other Nebraska presenters were:

 

Mary Barak-Bernhagen, Center for Advanced Airway Technology;
M. Susan Hallbeck, Ph.D., CAST;
Jeff Hawks, CAST;
Amy Lehman, CAST;
Mukul Mukherjee, Ph.D., CAST; and
Carl Nelson, Ph.D., CAST.

Loading